the Efficacy and Safety of Indobufen and Low-dose Aspirin in Different Regimens of Antiplatelet Therapy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 210 participants.

Also called NCT03230851

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 210 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03230851
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03230851. Randomized; single masking; primary purpose treatment. Start 2017-08-20 (anticipated); primary completion 2018-07-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
the Efficacy and Safety of Indobufen and Low-dose Aspirin in Different Regimens of Antiplatelet Therapy
Condition
Coronary Atherosclerosis
Intervention (Drug)
aspirin 100mg/d therapy
Intervention (Drug)
aspirin 100mg/2d therapy
Intervention (Drug)
aspirin 100mg/3d therapy
Intervention (Drug)
aspirin 50mg bid therapy
Intervention (Drug)
aspirin 75mg/d therapy
Intervention (Drug)
aspirin 50mg/d therapy
Intervention (Drug)
indobufen 100mg bid therapy
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University (class: other)

Record details

Record id
cardio:ct-nct03230851
Content hash
a8235f39a8f82308954f34cff6ebf190f9cffce9ae9f6daf3cb1bb3d25a8fd73